1. Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction
   Bjorn Baselet et al, 2020, Frontiers in Pharmacology CrossRef
2. Emerging Protective Actions of PGC-1α in Diabetic Nephropathy
   Yuqing She et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
3. From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases
   Lingge Zhang et al, 2023, Kidney Diseases CrossRef
4. Regulation of Mitochondrial Homeostasis and Nrf2 in Kidney Disease: Timing Is Critical
   Yuxian Zhuang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone
   Liwen Zhang et al, 2020, BioMed Research International CrossRef
6. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction
   Simeng Liu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
7. PGC-1α alleviates mitochondrial dysfunction via TFEB-mediated autophagy in cisplatin-induced acute kidney injury
   Longhui Yuan et al, 2021, Aging CrossRef
8. Morroniside Inhibits H2O2-Induced Podocyte Apoptosis by Down-Regulating NOX4 Expression Controlled by Autophagy In Vitro
   Xue Gao et al, 2020, Frontiers in Pharmacology CrossRef
9. Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease
   Jingsheng Chang et al, 2021, Frontiers in Medicine CrossRef
10. Mitochondrial quality control and its emerging role in the pathogenesis of diabetic kidney disease
    Jihyun Baek et al, 2023, Kidney Research and Clinical Practice CrossRef
11. Value of elastography point quantification in improving the diagnostic accuracy of early diabetic kidney disease
    Qiu-Yun Liu et al, 2019, World Journal of Clinical Cases CrossRef
12. The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
    Jianjun Gao et al, 2022, Frontiers in Pharmacology CrossRef